Cloned human telomeric DNA can integrate into mammalian chromosomes and seed the formation of new telomeres. This process occurs efficiently in three established human cell lines and in a mouse embryonic stem cell line. The newly seeded telomeres appear to be healed by telomerase. The seeding of new telomeres by cloned telomeric DNA is either undetectable or very inefficient in non-tumourigenic mouse or human somatic cell lines. The cytogenetic consequences of the seeding of new telomeres include large chromosome truncations but most of the telomere seeding events occur close to the pre-existing ends of natural chromosomes.
INTRODUCTION
Mammalian artificial chromosomes (MACs) would offer new opportunities for introducing large numbers of genes in a defined sequence environment into experimental animals, agricultural livestock, human somatic cells in vivo or mammalian cells in tissue culture (1) . In the yeast Saccharomyces cerevisiae transfonnation with telomeric DNA can be used to fragment both natural and artificial chromosomes (2) and has become the basis of a powerful technology for mapping sequences in natural and artificial yeast chromosomes (3, 4) . Preliminary evidence suggests that cloned telomeric DNA can also fragment mammalian chromosomes (5) . These observations indicate one route to the construction of a MAC. The first step in this involves fragmenting a natural mammalian chromosome with cloned telomeric DNA to produce a mini-chromosome. If such a mini-chromosome were small enough then it might be shuttled into an experimental environment where it could be analysed and manipulated more easily than in a mammalian cell. The nucleus of S. cerevisiae would be one such environment. If the mini-chromosome could be re-introduced into a mammalian cell and retain its integrity then it could become the basis of a MAC vector. Central to such a project is the use of cloned telomeric DNA as a reagent for fragmenting mammalian chromosomes.
The work described in this paper demonstrates that cloned human telomeric DNA can efficiently fragment mammalian chromosomes in several mammalian cell types including mouse embryonic stem (ES) cells. We show that when the cloned telomeric DNA seeds the formation of a new telomere it is healed by an enzymatic machinery with the characteristics of telomerase. We have characterized the products of fragmentation in a human cell line and in mouse ES cells by cytogenetic techniques. These include truncated centromere containing versions of natural chromosomes. We have not detected acentric fragmentation products. These results demonstrate that cloned telomeric DNA can be used as a reagent to manipulate the structure of mammalian chromosomes.
MATERIALS AND METHODS

DNA manipulations
Plasmids were constructed by standard procedures from the following fragments. We used the 2.2 kb AccI BamHI fragment of pSV2neo (6) as the source of the G418 resistance gene in the plasmids pTZsvneoproTEL, pBSsvneoTEL' and pTZsvneo. We used the 1.8 kb HindI BamHI fragment from pPGKneo(3 (referred to as pDEneo in ref. 7) as the source of the G418 resistance gene in the plasmid pBSPGKneoTEL. In the construction of this plasmid it was assumed that the early region polyadenylation sequence was in the same position with respect to the BamHI site as in pSV2neo. Subsequently we obtained sequence information about a precursor of pPGKneo,B and realised that the poladenylation sequence is inverted with respect to the BamHI site. Our construct therefore lacks a polyadenylation sequence. The telomeric DNA in pTZsvneoproTEL extended from the PstI site at position 678, 2.4 kb to a Bal3l deletion endpoint within TelSau2.0 (8) . The telomeric DNA in pBSsvneoTEL' (TEL' is referred to as TELHS in Itzahki et al., in press) and pBSPGKneoTEL extended from the TaqI site at postion 1831 to the deletion end point in the same deleted variant of TelSau2.0.
Extraction of genomic DNA, restriction enzyme digestion, Bal3l digestion, gel electrophoresis and filter hybridization were as described previously (8, 9) PCR and DNA sequencing The primers used to amplify the DNA healed onto the linearized pBSsvneoTEL' were termed 5-amp and C-strand. Their sequences were GACTGAGCTCAGGGGGAATTATCAAGC-TAT and TATAAGCTTCCCTAACCCTGACCCTAACCC respectively. Both were tagged at the 5' end with a stretch of DNA which was not complimentary to any known sequence in the potential target, which included sites for either SacI (5-amp) or Hindm (C-strand) and which, in the case of C-strand, served to enhance the amplification of the products of the initial round of amplification through subsequent rounds. The PCR reactions were carried out in a total volume of 0. Cell culture The human cell lines HeLa (10), EC27C4 (11), HT1080 (12) and the mouse cell line lOT1/2 (13) were all grown as adherent cells in Dulbecco's modified Eagles Medium supplemented with 10% Foetal Calf Serum, 2 mM L-glutamine and antibiotics (DMEM). The primary human cell line was established as an outgrowth from a portion of a foetal limb and was maintained in supplemented Dulbecco's modified Eagles medium further supplemented with DMEM conditioned by the growth of rat or mouse thymocytes. Cells of this line displayed density dependent inhibition of proliferation and started to senesce after about 25 passages. The mouse ES line, EFC-I, was maintained as described in ref. 14. Cells were transformed with DNA by electroporation using a Bio-Rad gene pulsar typically set to 400V/250 ,uF and transformants were selected by the growth of the cells in medium containing G418 at 250-300 ,ug/mL. The transformation efficiencies and protocols varied beween different cell lines and varied between experiments. The frequency of telomere seeding however was consistent for one cell line from experiment to experiment. No systematic differences were observed between the transformation efficiencies observed with pTZsvneoproTEL and pSV2neo suggesting that the effect of any adjacent telomere upon the expression of the svneo gene was small.
Cytogenetic analysis Chromosomes were prepared from the HT1080 cells which had been transfected with pTZsvneoproTEL by growing the cells for 12-16 hours in medium supplemented with 100 ,ug/mL 5-bromo-2-deoxyuridine and then for a further 5-12 hours in medium further supplemented with 10-5M thymidine. Colcemid was added to the culture ten minutes prior to harvesting to a final trypsinization using a solution of 40 mM KCl, 0.5 mM EDTA, 20 mM Hepes pH 7.4, fixed, spread and G banded by standard techniques (15) . In situ hybridization, detection and replication banding procedures were all performed as previously described (15) . The probe used for the in situ hybridization was a recombinant of the svneo fragment of pSV2neo in pTZ18R, referred to as pTZsvneo, labelled with 3H by nick translation. After the hybridization, exposure and developing of the photographic emulsion the chromosomes were banded with Hoechst 33258 and Giemsa. In situ hybridization of the chromosomes isolated from the ES cells was performed after chromosome isolation as described in ref. 16 restriction sites flanking the construct in four clones containing a single integration site and demonstrated that there was a single construct at each and that the integration sites differed from one another. The enzyme used in the experiment illustrated in Figure  2 was HindI; this cuts at a site 4.7 kb from the boundary with the telomeric DNA in pTZsvneoproTEL. If the heterogeneously sized fragments do correspond to newly seeded telomeres then the results of the experiment illustrated in Figure 2 suggest that they range between 1 kb and 20 kb in size. We wanted to confirm that the construct in this sort of clone lay at the end of a chromosomal DNA molecule and so we digested DNA extracted from three such clones with the exonucease Bal3 1. The digests were sampled periodically and analysed by restriction enzyme digestion, gel elecrophoresis and filter hybridization as described above. In each of these three clones the cognate restriction fragments were sensitive to the action ofthe Bal31 (Figure 3a-c) . In order to check the specificity of our approach we also analysed a clone which contained a construct which had stably integrated into a HeLa cell chromosome without appearing to seed the formation of a new telomere. As anticipated the cognate fragments in this clone were not detectably sensitive to the action of Bal3l (Figure 3d ). In the experiment illustrated in Figure 3 the DNA was digested with XbaI after Bal3l digestion. XbaI does not cut within the integrated pTZneoproTEL but was used in this experiment becase it allowed us to use a hybridization probe specific for the neo gene which produced lower nonspecific background after filter hybridization than the vector probe used in Figure 2 .
We tried to confirm the chromosomal location of the integrated construct by fluorescent in situ hybridization but were unable routinely to detect the short stretch of heterologous DNA in this construct using this technique.
We were interested to know whether the ability to seed new telomeres in this way required the precence of telomeric DNA Figure 4 demonstrate that the lengths of the endogenous telomeres range between 15 kb and 50 kb which is consistent with earlier measurements by de Lange (18) . The length of sequence added onto the telomeric construct in the 24 clones in which the construct had appeared to seed the formation of a new telomere was within the range 0-20 kb ( Figure 2 ) with an average of 4 kb. At the time of the analysis the clones had been through approximately 24 doublings since transfection with pTZsvneoproTEL. The difference in lengths between the endogenous telomeres and the construct-associated telomeres suggests that the construct had seeded the formation of new telomeres rather than integrated into pre-existing telomeres.
In order to investigate the mechanism of healing of the newly seeded telomeres we designed an experiment using a strategy established by Murray and colleagues (19) in an investigation of the mechanism of healing of cloned telomeric DNA in S.cerevisiae. These workers introduced a construct containing cloned telomeric DNA with a non-telomeric polylinker extension into yeast and observed that the construct was healed with telomeric DNA but retained some or all of the polylinker sequences. They concluded that the construct was healed by a mechanism which did not involve sequence conversion or recombination and was likely to involve telomerase. We therefore assembled the plasmid pBSsvneoTEL' (Figures 1 and 5 ). This plasmid differs from pTZsvneoproTEL in two significant respects: firstly, it contains only 176 bp of proterninal DNA and secondly, the extreme terminus of the molecule has been engineered to enable details of the processing of the end of the construct to be examined by PCR and sequencing (Figure 5a ). When pBSsvneoTEL' is linearized by Apal the telomeric end of the molecule consists of 15 bp of non-telomeric DNA, 2 copies of the TTAGGG repeat and then 28 bp and 4 unpaired 3' residues of non-telomeric DNA (Figure 5a ). The recessed 15 bp stretch of non-telomeric DNA acts as a primer binding site to enable the DNA healed onto the construction to be specifically amplified by the PCR. The 32 residue stretch of non-telomeric DNA at the very end of the molecule acts as an indicator of the specificity for the healing reaction. We needed to establish that the presence of only 176 bp of proterminal DNA did not impair the functional properties of the TTAGGG array before we used this construct to examine the mechanism of healing of the newly seeded telomeres. There is a unique Asp718I site between the terminal 32 residue stretch of non-telomeric DNA and the adjacent TTA-GGG sequence and so in initial experiments we linearized pBSsvneoTEL' with Asp718I, transfected the plasmid into HeLa cells by electroporation, isolated clones and analyzed the extracted in pTZsvneoproTEL, but absent from pBSsvneoTEL', were without significance for this aspect of telomere function. In five of the clones in which the construct had seeded the formation of a new telomere we were able to generate a PCR product which hybridized to 32P-(TTAGGG)4 when we amplified with primers complimentary to the G rich strand of the human telomeric repeat and to the 15 basepair recessed primer binding site. We cloned and sequenced one of the PCR products and demonstrated that the construct had been healed with (TTAGGG)n on or within the (TTAGGG)2 sequence (not shown). We interpreted the failure to generate a PCR product in other fifteen clones where the construct had seeded the formation of a new telomere as indicating that the construct had been healed behind the boundary of the (TTAGGG)2 repeat and thus had lost the sequence complimentary to the specific primer. In the next experiment we linearized the construction with ApaI, electroporated HeLa cells and analysed 39 stably tranfected clones. In 17 of these the construct was associated with a newly seeded telomere suggesting that the non-telomeric DNA extension did not significantly impair the functional properties of the cloned telomeric DNA. Seven of these clones yielded a PCR product. We cloned and sequenced two or three copies of the individual products. The results ( Figure  Sb) We analysed the lengths of the newly seeded telomeres and of the endogenous telomeres at intervals corresponding to 60 population doublings for a total of 300 population doublings. The average lengths of the newly seeded telomeres progressively approached those of the endogenous telomeres and became more heterogeneous. Assuming a uniform growth rate for all the cells in the culture, the maximum rate of telomere growth in the newly seeded telomere was approximately 130 bp per cell doubling (data not shown). We did not detect the appearance of any discretely sized fragments in the course of this analysis indicating that, once they are formed, the telomeres are stable. In approximately half of the clones which had been stably transfected with either of the telomeric constructs, the construct had appeared to fail to seed the formation of a new telomere. We were also interested to know the fate of the cloned telomeric DNA in these clones. In order to address this point we made use of a unique EcoNI site present in the proterminal DNA of pTZsvneoproTEL. Restriction analysis demonstated that this site was undetectable in 13 out of 15 integration sites associated with the failure to seed a new telomere (data not shown). The site was detectable in each of the 22 sites in the 22 clones in which pTZsvneoproTEL had seeded the formation of a new telomere. These results suggest that the failure of the construct to seed a new telomere is associated with the loss of telomeric DNA from the construct. We analysed the structure of the integration site in one such clone at intervals of 60 population doublings for a total of 300 population doublings and, as anticipated, failed to detect any evidence of resolution of the construct into a telomere. Similarly, restriction site analysis of the DNA flanking the integration sites in one clone in which the construct existed in both telomeric and non-telomeric locations demonstated two independent sites of integration. These results thus suggest that a 1kb interstitial stretch of (TTAGGG) 11 were associated with the formation of a new telomere. During the initial stages of this analysis we noted that the newly seeded telomeres were associated with a much longer stretch of telomeric DNA in the ES cells than in any of the other cell types ( Figure 6 ). Two practical consequences of this difference are that reliable detection of telomere seeding in ES cells requires the use of pulsed field gel electrophoresis and that the ES cell DNA is best extracted in agarose plugs in order to retain its integrity prior to analysis. The observation that the construct is often associated with a long stretch of telomeric DNA is also consistent with the possibility that in some of these cell lines it has simply integrated into pre-existing telomeres. However we assume that ES cells are not qualitatively different from the other cells in which telomere seeding is observed and that the our construct has in fact seeded the formation of new telomeres in a majority of the ES cell clones where it has been healed with a large tract of DNA. Cytogenetical analyses described below support this view. We were curious to know whether the ability of the ES cells to heal the cloned telomeric DNA with a long stretch of (TTAGGG)2 was a consequence of their being of mouse or of germ line origin. We (Figure 7 ). This probe recognizes about 12 different telomeric loci and a single complex non-telomeric locus (8) . The telomeric loci correspond to the heterogeneous sized fragments which in the parental line are of average of 6 kb in size. In the stably transfected clones the heterogeneously sized fragments are longer than in the parental clones and range in size between 9.4 kb (clone 5) and 15.0 kb (clone 2). These results suggest that the telomeres in these clones have grown during the course of the experiments and that the clones contain functional telomerase. Figure 8a ) and in clone 16.1 it was located at the end of chromosome 2 short arm (Figure 8b ). We could however detect no chromosome truncation in either of these clones. In light of the biochemical evidence presented above we interpret this result to suggest that in each of these clones the cloned telomeric DNA has integrated close to a pre-existing natural telomere. It was particularly important to confirm that the cloned telomeric DNA could seed the formation of a new telomere in ES cells and so we examined six clones where the molecular analysis indicated that the pBSPGKneoTEL had stably integrated into the ES cell genome. There was no evidence of chromosome truncation in four of these clones however two of the clones contained cytogenetically distinct truncated versions of chromosome 14 and were hemizygous for sequences distal of the truncation breakpoint. In situ hybridization analysis of one of these clones demonstrated that the pPGKneoTEL lay at the breakpoint of the truncated copy of chromosome 14 ( Figure 9 ). The simplest interpretation of all of these data is that when cloned telomeric DNA integrates into mammalian chromosomes and seeds the formation of a new telomere it tends to do so near the end of a pre-existing chromosome. It can however occasionally integrate into the bulk of a chromosome and cause a cytogenetically detectable truncation.
We were also interested to know whether there were any cytogenetic consequences of a construct containing cloned telomeric DNA integrating into a chromosome and failing to seed the formation of a new telomere. We analysed one HT1080 clone, (Figure 8c ). In clone 6.3 the construct had integrated into Xq26 without being associated with a cytogenetically detectable rearrangement.
DISCUSSION
We initiated this project in order to determine whether we could use cloned telomeric DNA to fragment mammalian chromosomes. The combination of molecular and cytogenetic analyses described here, together with the results of Itzahki and colleagues (in press) showing truncation of human chromosome 1 by targeted telomere directed breakage, demonstrate that we can. This process occurs efficiently in the established cell lines HeLa, EC27C4 and HT1080 and in the mouse embryonic stem cell line EFC but is either inefficient or undetectable in mouse 10Tl/2 cells or in human primary fibroblasts. The cytogenetic consequences of the seeding of a new telomere include the generation of large chromosome truncations but most of the integration events associated with the formation of newly seeded telomeres appear to occur close to the pre-existing ends of natural chromosomes and to generate, consequently, truncations which are too small to detect by cytogenetic techniques. These observations raise two questions. Why does cloned telomeric DNA not detectably seed the formation of new telomeres in human primary fibroblasts and why do most of the seeding events appear to occur close to the pre-existing ends of chromosomes?
We analysed 54 sites where pTZsvneoproTEL had integrated into the genome of a human primary fibroblast line but at none of these had a new telomere been seeded. One possible explanation for a failure to detect telomere seeding might be an absence of telomerase from the primary fibroblast line (20) . If this was the case then the cloned telomeric DNA could have seeded the formation of new telomeres but the telomeres would have progressively shorted during culture as a result of exonuclease action and a failure to replicate the 5' end of the telomeric DNA. If the newly seeded telomere had shortened until it was too small to function then the remnants of the construction would either have been lost as a result of further sequence degradation or would have become the junction of a fusion with another chromosome. If the selectable marker gene in the construct had been destroyed then the clone, grown in the presence of the antibiotic G418 would have died. If the telomere had failed and the construction had fused with another chromosome then the construct would have appeared to have failed to seed the formation of a new telomere. The observation that the endogenous telomeres in the stably transfected clones were longer than those in the parental line however argues against telomerase deficiency being the basis of the correct explanation of our results. Chromosome structure is more stable in primary fibroblasts than in transformed cells and it is possible that the failure to detect telomere seeding by transfected telomeric DNA reflects active repair and recombination pathways which tend to integrate sequences into the genomic DNA of these cells in such a way as to prevent chromosome breakage. Our experiment however does not allow an unambiguous explanation of our results; it is, for example, possible that telomerase was not present in the primary fibroblasts at the time of transfection and that any newly seeded telomeres were lost prior to expression of any telomerase activity. Alternatively we may have selected for those clones with long telomeres. Understanding chromosome breakage, telomere seeding and the role of telomerase will require reconstitution of the events in vitro from defined components.
It is striking that most of the seeding events that we detected appear to occur close to the pre-existing ends of the chromosomes. It is unlikely that this will prevent cloned telomeric DNA being used to systematically fragment mammalian chromosomes. In experiments described elsewhere we have truncated human chromosome 1 at band lp35 by targeting telomeric DNA to the 6-16 locus (Itzhaki et al. in press). Nevertheless more work will be needed to establish how reliably we can use sequence targeting and telomere directed chromosome fragmentation to systematically fragment mammalian chromosomes. It seems particularly important that this work be carried out in ES cells where, suprisingly, two of the breaks that we detected were on chromosome 14. It might be thought that that our failure to detect a set of apparently random chromosome truncations was caused by the reduced viability of cells hemizygous for large chromosomal regions. This explanation is unsatisfactory for two reasons. Firstly cells with large truncations of chromosomal material induced by therapeutic irradiation are viable in vivo for many years (21) . Similarly mice hemizygous for large chromosomal regions can be viable (Cattanach et al., in press). Secondly the HT1080 karyotype appears variable and changes in ploidy which might compensate for the genetic consequences of any truncation should occur readily. We speculate that the non-random pattern of integration of the functioning telomeric DNA reflects an interaction between the cloned telomeric DNA in the construct and telomere binding proteins located at the nuclear periphery prior to the integration of the construct into the chromosome. Cytogenetic analysis also failed to detect large acentric fragments of chromosomal DNA in the clones containing newly seeded telomeres. This may reflect our analysis of relatively few clones by cytogenetic techniques, the fact that most of the breaks generate fragments too small to detect or the mitotic instability of such fragments.
Despite these limitations in our understanding of the molecular events which occur when cloned telomeric DNA breaks a chromosome and seeds the formation of a new telomere it seems reasonable to conclude that we can use cloned telomeric DNA as a reagent for both structural and functional studies of mammalian chromosomes in a variety of transformed cell lines and in the mouse germ line. Furthermore, the observation that cloned telomeric DNA can break chromosomes in mammalian cells which readily integrate non-homologous DNA into chromosomes suggests that telomeric DNA might be used to manipulate chromosome structure in a wide variety of plants and animals.
